Analyze Diet
Equine veterinary journal2025; doi: 10.1111/evj.14461

A genome-wide association study for recurrent laryngeal neuropathy in the Thoroughbred horse identifies a candidate gene that regulates myelin structure.

Abstract: Equine recurrent laryngeal neuropathy (RLN) is an economically important upper respiratory tract (URT) disease with a genetic contribution to risk, but genetic variants independent of height have not been identified for Thoroughbreds. The method of clinical assessment for RLN is critical to accurately phenotype groups for genetic studies. Objective: To identify genetic risk loci for RLN in Thoroughbreds in a genome-wide association study (GWAS) following high-resolution phenotyping. Methods: Case-control. Methods: Thoroughbred horses were characterised as RLN cases and controls using resting and exercising URT endoscopic examinations and laryngeal ultrasonography, with the case-cohort supplemented using a questionnaire. Genotypes for 43 831 autosomal single-nucleotide polymorphisms (SNPs) from n = 235 horses (n = 110 cases; n = 125 controls) were used to estimate trait heritability and identify significantly associated SNPs in a GWAS. Haplotypes were examined in cases and controls and risk allele frequencies were examined in a population cohort (n = 3126). Results: Heritability was h = 0.30 including sex and 5PCs as covariates. A SNP on ECA20 located between candidate genes, DAAM2 and LRFN2, was significantly associated with RLN. Six index SNPs with allelic effect sizes OR = 1.5-2.9 were identified on ECA1, ECA14, and ECA20 close to candidate genes ATPA10, KCNN2, and TFAP2A. Eleven ECA20 SNPs defined seven haplotypes with homozygous H2/H2 horses having a 3.1× higher risk of RLN. Risk alleles segregate in the population, and stallions are carriers. Conclusions: The main study population was young. Horses in the control group had no evidence of RLN as 2- or 3-year olds but may have developed RLN later. Conclusions: Genetic markers for RLN were identified which may be useful for the development of a polygenic risk score. Candidate genes with functions in neuropathies may further the understanding of RLN pathobiology. Unassigned: La neuropatía laríngea recurrente (RNL) en el equino es una enfermedad del tracto respiratorio superior (URT) económicamente importante con una contribución genética al riesgo, cuyas variantes genéticas independientes a la altura no han sido identificadas en el Fina Sangre de Carrera. El método de diagnóstico clínico de RNL es crítico para determinar grupos fenotípicos para estudios genéticos. Objective: Identificar loci de riesgo genético para RLN en Fina Sangre de Carrera en un estudio de asociación de genoma generalizado (GWAS) después de fenotipificación de alta resolución. DISEÑO DEL ESTUDIO: Caso‐control. MÉTODOS: Caballos Fina Sangre de Carrera fueron caracterizados como casos RNL y controles usando examinaciones en reposo y durante ejercicio por endoscopia del URT y ultrasonido de la laringe, con la cohorte de casos suplementados usando un cuestionario. Lo genotipos de 43 831 polimorfismos autosomales de nucleótido singular (SNPs) de n = 235 caballos (n = 110 casos; n = 125 controles) fueron usados para estimar la heredabilidad del rasgo e identificar SNPs asociados en forma significativa en un GWAS. Haplotipos fueron examinados en los casos y controles, y las frecuencias de los alelos de riesgo fueron examinadas en una cohorte de la población (n = 3126). Results: La heredabilidad fue de h = 0.30 incluyendo sexo y 5PCs como covariantes. Un SNP en ECA20 localizado entre los genes candidatos DAAM2 y LRFN2, fue asociado en forma significativa con la RLN. Seis SNPs índices con efecto alélico de tamaño OR = 1.5–2.9 fueron identificados en ECA1, ECA14 y ECA20 cerca de los genes candidatos ATPA10, KCNN2, y TFAP2A. Once SNPs en ECA20 definieron siete haplotipos en caballos homocigotos H2/H2 de tener un riesgo 3.1× mayor de RLN. Los alelos de riesgo son segregados en la población y los potros son portadores. Unassigned: La población principal era joven. Los caballos en el grupo control no tenía evidencia de RLN a los dos o tres años, pero pueden haber desarrollado RLN más tarde. Conclusions: Se identificaron marcadores genéticos para RLN los cuales pueden ser útiles para desarrollar un puntaje de riesgo poligénico. Los genes candidatos con funciones en neuropatías podrían aumentar el conocimiento de la patobiología de RLN.
Publication Date: 2025-01-10 PubMed ID: 39791379DOI: 10.1111/evj.14461Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research conducted a genetic study on Thoroughbred horses to identify genes associated with recurrent laryngeal neuropathy (RLN), a significant respiratory disease. The study found SNPs (single-nucleotide polymorphisms), particularly on gene ECA20, associated with higher risks of RLN. Further exploration on the mentioned SNPs could offer insights into understanding the disease and developing genetic risk scores.

Objective of the Study

  • The main aim of this study was to identify the genetic risk factors of RLN in Thoroughbred horses by conducting a GWAS (genome-wide association study). This research aimed to offer an accurate genetic framework and thus contribute to the broader understanding and possible future treatment of the disease.

Methods Used in The Study

  • Researchers characterized Thoroughbred horses as RLN cases and controls by using resting and exercising upper respiratory tract (URT) endoscopic examinations and laryngeal ultrasonography.
  • The case-cohort was supplemented by a questionnaire to gather additional data.
  • The genotypes for 43,831 autosomal single-nucleotide polymorphisms (SNPs) from 235 horses were used to estimate trait heritability and identify significantly associated SNPs in the GWAS.
  • Haplotypes were examined in cases and controls, and risk allele frequencies were examined in a population cohort.

Findings from The Study

  • The heritability factor was found to be 0.30 when accounting for sex and 5PCs (Principal Components) as covariates. This highlights a certain level of genetic predisposition to the disease.
  • A SNP on gene ECA20 located between the DAAM2 and LRFN2 genes was found to be significantly associated with RLN. Six index SNPs were identified on genes ECA1, ECA14, and ECA20 close to candidate genes ATPA10, KCNN2, and TFAP2A.
  • Seven haplotypes were defined by eleven ECA20 SNPs, with homozygous H2/H2 horses having a 3.1x higher risk of RLN. This means there was a frequent presence of certain SNPs in horses with RLN, suggesting a linkage to the disease.

Conclusions from The Study

  • The study found genetic markers for RLN which can be useful in the development of a polygenic risk score. This could be applied in predictive tests for young Thoroughbred horses.
  • It was observed that the control group had no evidence of RLN as 2- to 3-year olds, but they may have developed RLN at a later age. This indicates the possibility of late-onset of the disease.
  • The candidate genes identified, which are known to have roles in neuropathies, could provide further insight into the pathobiology of RLN, advancing our understanding of neuropathic diseases in general.

Cite This Article

APA
McGivney CL, McGivney BA, Farries G, Gough KF, Han H, Holtby AR, MacHugh DE, Katz LM, Hill EW. (2025). A genome-wide association study for recurrent laryngeal neuropathy in the Thoroughbred horse identifies a candidate gene that regulates myelin structure. Equine Vet J. https://doi.org/10.1111/evj.14461

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English

Researcher Affiliations

McGivney, Charlotte L
  • UCD School of Agriculture and Food Science, University College Dublin, Dublin, Ireland.
McGivney, Beatrice A
  • Plusvital Ltd., The Highline, Dun Laoghaire Industrial Estate, Dublin, Ireland.
Farries, Gabriella
  • UCD School of Agriculture and Food Science, University College Dublin, Dublin, Ireland.
Gough, Katie F
  • UCD School of Agriculture and Food Science, University College Dublin, Dublin, Ireland.
Han, Haige
  • Plusvital Ltd., The Highline, Dun Laoghaire Industrial Estate, Dublin, Ireland.
Holtby, Amy R
  • Plusvital Ltd., The Highline, Dun Laoghaire Industrial Estate, Dublin, Ireland.
MacHugh, David E
  • UCD School of Agriculture and Food Science, University College Dublin, Dublin, Ireland.
  • UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland.
Katz, Lisa Michelle
  • UCD School of Veterinary Medicine, University College Dublin, Dublin, Ireland.
Hill, Emmeline W
  • UCD School of Agriculture and Food Science, University College Dublin, Dublin, Ireland.
  • Plusvital Ltd., The Highline, Dun Laoghaire Industrial Estate, Dublin, Ireland.

Grant Funding

  • 11-PI-1166 / Science Foundation Ireland

References

This article includes 53 references
  1. Brown JA, Hinchcliff KW, Jackson MA, Dredge AF, O'Callaghan RA, McCaffrey JR. Prevalence of pharyngeal and laryngeal abnormalities in Thoroughbreds racing in Australia, and their association with performance.. Equine Vet J 2005;37(5):397–401.
  2. Anderson BH, Kannegieter NJ, Goulden BE. Endoscopic observations on laryngeal symmetry and movements in young racing horses.. N Z Vet J 1997;45:188–192.
  3. Lane JG, Bladon B, Little DR, Naylor JR, Franklin SH. Dynamic obstructions of the equine upper respiratory tract. Part 2: comparison of endoscopic findings at rest and during high‐speed treadmill exercise of 600 Thoroughbred racehorses.. Equine Vet J 2006;38:401–407.
  4. Sweeney CR, Maxson AD, Soma LR. Endoscopic findings in the upper respiratory tract of 678 Thoroughbred racehorses.. J Am Vet Med Assoc 1991;198:1037–1038.
  5. Witte SH, Witte TH, Harriss F, Kelly G, Pollock P. Association of owner‐reported noise with findings during dynamic respiratory endoscopy in Thoroughbred racehorses.. Equine Vet J 2011;43:9–17.
  6. Draper ACE, Piercy RJ. Pathological classification of equine recurrent laryngeal neuropathy.. J Vet Intern Med 2018;32:1397–1409.
    doi: 10.1111/jvim.15142google scholar: lookup
  7. Boyko AR, Brooks SA, Behan‐Braman A, Castelhano M, Corey E, Oliveira KC. Genomic analysis establishes correlation between growth and laryngeal neuropathy in Thoroughbreds.. BMC Genomics 2014;15:259.
    doi: 10.1186/1471-2164-15-259google scholar: lookup
  8. Ibi T, Miyake T, Hobo S, Oki H, Ishida N, Sasaki Y. Estimation of heritability of laryngeal hemiplegia in the thoroughbred horse by Gibbs sampling.. J Equine Sci 2003;14:81–86.
  9. Dupuis MC, Zhang Z, Druet T, Denoix J‐M, Charlier C, Lekeux P. Results of a haplotype‐based GWAS for recurrent laryngeal neuropathy in the horse.. Mamm Genome 2011;22(9‐10):613–620.
    doi: 10.1007/s00335-011-9337-3google scholar: lookup
  10. Tetens J, Widmann P, Kuhn C, Thaller G. A genome‐wide association study indicates LCORL/NCAPG as a candidate locus for withers height in German Warmblood horses.. Anim Genet 2013;44:467–471.
    doi: 10.1111/age.12031google scholar: lookup
  11. Signer‐Hasler H, Flury C, Haase B, Burger D, Simianer H, Leeb T. A genome‐wide association study reveals loci influencing height and other conformation traits in horses.. PLoS One 2012;7:e37282.
  12. Metzger J, Schrimpf R, Philipp U, Distl O. Expression levels of LCORL are associated with body size in horses.. PLoS One 2013;8:e56497.
  13. Makvandi‐Nejad S, Hoffman GE, Allen JJ, Chu E, Gu E, Chandler AM. Four loci explain 83% of size variation in the horse.. PLoS One 2012;7(7):e39929.
  14. Dixon PM, McGorum BC, Railton DI, Hawe C, Tremaine WH, Pickles K. Laryngeal paralysis: a study of 375 cases in a mixed‐breed population of horses.. Equine Vet J 2001;33(5):452–458.
  15. Goulden BE, Anderson LJ. Equine laryngeal hemiplegia, part I: physical characteristics of affected animals.. N Z Vet J 1981;29:151–154.
  16. McGivney CL, Gough KF, McGivney BA, Farries G, Hill EW, Katz LM. Exploratory factor analysis of signalment and conformational measurements in Thoroughbred horses with and without recurrent laryngeal neuropathy.. Equine Vet J 2019;51(2):179–184.
    doi: 10.1111/evj.12984google scholar: lookup
  17. Garrett KS, Woodie JB, Embertson RM. Association of treadmill upper airway endoscopic evaluation with results of ultrasonography and resting upper airway endoscopic evaluation.. Equine Vet J 2011;43:365–371.
  18. Hammer EJ, Tulleners EP, Parente EJ, Martin BB. Videoendoscopic assessment of dynamic laryngeal function during exercise in horses with grade‐III left laryngeal hemiparesis at rest: 26 cases (1992‐1995).. J Am Vet Med Assoc 1998;212:399–403.
  19. McGivney CL, Sweeney J, Gough KF, Hill EW, Katz LM. Serial evaluation of resting and exercising overground endoscopic examination results in young Thoroughbreds with no treatment intervention.. Equine Vet J 2019;51:192–197.
    doi: 10.1111/evj.12994google scholar: lookup
  20. McGivney CL, Sweeney J, David F, O'Leary JM, Hill EW, Katz LM. Intra‐ and interobserver reliability estimates for identification and grading of upper respiratory tract abnormalities recorded in horses at rest and during overground endoscopy.. Equine Vet J 2017;49:433–437.
    doi: 10.1111/evj.12653google scholar: lookup
  21. Dixon PM, McGorum BC, Railton DI, Hawe TW, Pickles K, McCann J. Clinical and endoscopic evidence of progression in 152 cases of equine recurrent laryngeal neuropathy (RLN).. Equine Vet J 2002;34(1):29–34.
  22. Chalmers HJ, Yeager AE, Cheetham J, Ducharme N. Diagnostic sensitivity of subjective and quantitative laryngeal ultrasonography for recurrent laryngeal neuropathy in horses.. Vet Radiol Ultrasound 2012;53:660–666.
  23. Dixon PM, Robinson E, Wade JF. Proceedings of a workshop on equine recurrent laryngeal neuropathy.. Havemeyer Found Monogr Ser 2003;11:93–97.
  24. Chalmers HJ, Cheetham J, Yeager AE, Ducharme NG. Ultrasonography of the equine larynx.. Vet Radiol Ultrasound 2006;47:476–481.
  25. Browning BL, Browning SR. A unified approach to genotype imputation and haplotype‐phase inference for large data sets of trios and unrelated individuals.. Am J Hum Genet 2009;84:210–223.
  26. Chang CC, Chow CC, Tellier LC, Vattikuti S, Purcell SM, Lee JJ. Second‐generation PLINK: rising to the challenge of larger and richer datasets.. Gigascience 2015;4:7.
    doi: 10.1186/s13742-015-0047-8google scholar: lookup
  27. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome‐wide complex trait analysis.. Am J Hum Genet 2011;88:76–82.
  28. Purcell S, Neale B, Todd‐Brown K, Thomas L, Ferreira MAR, Bender D. PLINK: a tool set for whole‐genome association and population‐based linkage analyses.. Am J Hum Genet 2007;81:559–575.
    doi: 10.1086/519795google scholar: lookup
  29. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases.. Nat Genet 2008;40:695–701.
    doi: 10.1038/ng.f.136google scholar: lookup
  30. Shi H, Medway C, Brown K, Kalsheker N, Morgan K. Using Fisher's method with PLINK ‘LD clumped’ output to compare SNP effects across genome‐wide association study (GWAS) datasets.. Int J Mol Epidemiol Genet 2011;2:30–35.
  31. Medway C, Shi H, Bullock J, Black H, Brown K, Vafadar‐Isfahani B. Using in silico LD clumping and meta‐analysis of genome‐wide datasets as a complementary tool to investigate and validate new candidate biomarkers in Alzheimer's disease.. Int J Mol Epidemiol Genet 2010;1:134–144.
  32. O'Connell J, Gurdasani D, Delaneau O, Pirastu N, Ulivi S, Cocca M. A general approach for haplotype phasing across the full spectrum of relatedness.. PLoS Genet 2014;10:e1004234.
  33. Finno CJ. Science‐in‐brief: genomic and transcriptomic approaches to the investigation of equine diseases.. Equine Vet J 2022;54:444–448.
    doi: 10.1111/evj.13549google scholar: lookup
  34. Schulze TG, McMahon FJ. Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping.. Hum Hered 2004;58:131–138.
    doi: 10.1159/000083539google scholar: lookup
  35. Beard WL, Hayes HM. Risk factors for laryngeal hemiplegia in the horse.. Prev Vet Med 1993;17:57–63.
  36. Flash ML, Crabb HK, Hitchens PL, Firestone SM, Stevenson MA, Gilkerson JR. Factors associated with racing performance and career duration for Victorian‐born Thoroughbreds.. Aust Vet J 2022;100:48–55.
    doi: 10.1111/avj.13128google scholar: lookup
  37. Barbeira AN, Bonazzola R, Gamazon ER, Liang Y, Park Y, Kim‐Hellmuth S. Exploiting the GTEx resources to decipher the mechanisms at GWAS loci.. Genome Biol 2021;22:49.
  38. Nasser J, Bergman DT, Fulco CP, Guckelberger P, Doughty BR, Patwardhan TA. Genome‐wide enhancer maps link risk variants to disease genes.. Nature 2021;593:238–243.
  39. Cristobal CD, Wang C‐Y, Zuo Z, Smith JA, Lindeke‐Myers A, Bellen HJ. Daam2 regulates myelin structure and the oligodendrocyte actin cytoskeleton through Rac1 and gelsolin.. J Neurosci 2022;42:1679–1691.
  40. Bauer NG, Richter‐Landsberg C, Ffrench‐Constant C. Role of the oligodendroglial cytoskeleton in differentiation and myelination.. Glia 2009;57:1691–1705.
    doi: 10.1002/glia.20885google scholar: lookup
  41. Bercury KK, Macklin WB. Dynamics and mechanisms of CNS myelination.. Dev Cell 2015;32:447–458.
  42. Fabrizi GM, Cavallaro T, Angiari C, Cabrini I, Taioli F, Malerba G. Charcot‐Marie‐Tooth disease type 2E, a disorder of the cytoskeleton.. Brain 2007;130:394–403.
    doi: 10.1093/brain/awl284google scholar: lookup
  43. Boyer O, Nevo F, Plaisier E, Funalot B, Gribouval O, Benoit G. INF2 mutations in Charcot‐Marie‐Tooth disease with glomerulopathy.. N Engl J Med 2011;365:2377–2388.
    doi: 10.1056/nejmoa1109122google scholar: lookup
  44. Cercone M, Hokanson CM, Olsen E, Ducharme NG, Mitchell LM, Piercy RJ. Asymmetric recurrent laryngeal nerve conduction velocities and dorsal cricoarytenoid muscle electromyographic characteristics in clinically normal horses.. Sci Rep 2019;9:2713.
  45. Homma S, Shimada T, Hikake T, Yaginuma H. Expression pattern of LRR and Ig domain‐containing protein (LRRIG protein) in the early mouse embryo.. Gene Expr Patterns 2009;9:1–26.
    doi: 10.1016/j.gep.2008.09.004google scholar: lookup
  46. Brouwer M, Farzana F, Koopmans F, Chen N, Brunner JW, Oldani S. SALM1 controls synapse development by promoting F‐actin/PIP2‐dependent neurexin clustering.. EMBO J 2019;38:e101289.
    doi: 10.15252/embj.2018101289google scholar: lookup
  47. Dalva MB, McClelland AC, Kayser MS. Cell adhesion molecules: signalling functions at the synapse.. Nat Rev Neurosci 2007;8:206–220.
    doi: 10.1038/nrn2075google scholar: lookup
  48. Li Y, Kim R, Cho YS, Song WS, Kim D, Kim K. Lrfn2‐mutant mice display suppressed synaptic plasticity and inhibitory synapse development and abnormal social communication and startle response.. J Neurosci 2018;38:5872–5887.
  49. Zhu X, Libby RG, de Vries WN, Smith RS, Wright DL, Bronson RT. Mutations in a P‐type ATPase gene cause axonal degeneration.. PLoS Genet 2012;8:e1002853.
  50. Zhang F, Gu X, Yi S, Xu H. Dysregulated transcription factor TFAP2A after peripheral nerve injury modulated Schwann cell phenotype.. Neurochem Res 2019;44:2776–2785.
  51. Brooks SA, Stick J, Braman A, Palermo K, Robinson NE, Ainsworth DM. Identification of loci affecting sexually dimorphic patterns for height and recurrent laryngeal neuropathy risk in American Belgian Draft Horses.. Physiol Genomics 2018;50(12):1051–1058.
  52. Choi SW, Mak TS, O'Reilly PF. Tutorial: a guide to performing polygenic risk score analyses.. Nat Protoc 2020;15:2759–2772.
    doi: 10.1038/s41596-020-0353-1google scholar: lookup
  53. Lewis CM, Vassos E. Polygenic risk scores: from research tools to clinical instruments.. Genome Med 2020;12:44.

Citations

This article has been cited 0 times.